Citation Impact
Citing Papers
2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy
2014 Standout
Use of Sildenafil (Viagra) in Patients With Cardiovascular Disease
1999
Spin–orbit interactions of light
2015 Standout
Current concepts in the mechanisms and management of drug-induced QT prolongation and torsade de pointes
2007
Effect of Fish Oil on Ventricular Tachyarrhythmia and Death in Patients With Implantable Cardioverter Defibrillators
2006
Regulation and function of the cyclic nucleotide phosphodiesterase (PDE3) gene family
2000
Life‐threatening ventricular tachycardia due to liquorice‐induced hypokalaemia
1999
Nitric Oxide and cGMP Signaling
1995 StandoutNobel
Interactions of Herbs with Cytochrome P450
2003
The Utilization of the Implantable Defibrillator—a European Enigma
2000
Type III cGMP-inhibited cyclic nucleotide phosphodiesterases (PDE 3 gene family)
1995
Usefulness of microvolt T-wave alternans for prediction of ventricular tachyarrhythmic events in patients with dilated cardiomyopathy: results from a prospective observational study
2003
Review of Pharmacological Effects of Glycyrrhiza sp. and its Bioactive Compounds
2008 Standout
Descending control of pain
2002 Standout
Cyclic nucleotide phosphodiesterase (PDE) superfamily: A new target for the development of specific therapeutic agents
2005 Standout
Cyclic Nucleotide Phosphodiesterases: Molecular Regulation to Clinical Use
2006 Standout
Cyclic Nucleotide Hydrolysis in Bovine Aortic Endothelial Cells in Culture: Differential Regulation in Cobblestone and Spindle Phenotypes
2000
Erectile Dysfunction
2000 Standout
Clusters of ventricular tachycardias signify impaired survival in patients with idiopathic dilated cardiomyopathy and implantable cardioverter defibrillators
2000
Characterisation of cyclic nucleotide phosphodiesterase isoforms in the media layer of the main pulmonary artery
2002
Cardiac-Resynchronization Therapy for the Prevention of Heart-Failure Events
2009 Standout
2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults
2009 Standout
VEGF-induced HUVEC migration and proliferation are decreased by PDE2 and PDE4 inhibitors
2003
A brief review on the history of human functional near-infrared spectroscopy (fNIRS) development and fields of application
2012 Standout
ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities
2008 Standout
Omega-3 Polyunsaturated Fatty Acids and Cardiovascular Diseases
2009 Standout
Anti-TNF-α Properties of New 9-Benzyladenine Derivatives with Selective Phosphodiesterase-4- Inhibiting Properties
2001
Randomized Trial of Cardiac Resynchronization in Mildly Symptomatic Heart Failure Patients and in Asymptomatic Patients With Left Ventricular Dysfunction and Previous Heart Failure Symptoms
2008
Occurrence of implantable defibrillator events in patients with syncope and nonischemic dilated cardiomyopathy
2001
cGMP-Dependent Protein Kinases and cGMP Phosphodiesterases in Nitric Oxide and cGMP Action
2010 Standout
Transdermal drug delivery
2008 Standout
Fish Intake, Contaminants, and Human Health
2006 Standout
Cytochemical distribution of cyclic AMP-dependent 3′,5′-nucleotide phosphodiesterase in the rat myocardium
1996
Usefulness of Omega-3 Fatty Acids and the Prevention of Coronary Heart Disease
2005
Effect of sildenafil on cyclic nucleotide phosphodiesterase activity, vascular tone and calcium signaling in rat pulmonary artery
2003
Chelerythrine, a protein kinase C inhibitor, interacts with cyclic nucleotide phosphodiesterases
1997
Antiarrhythmic Effects of Omega-3 Fatty Acids
2006
Do Current Dual Chamber Cardioverter Defibrillators Have Advantages Over Conventional Single Chamber Cardioverter Defibrillators in Reducing Inappropriate Therapies? A Randomized, Prospective Study
2001
Rolipram increases cyclic GMP content in L-arginine-treated cultured bovine aortic endothelial cells
1995
Hypertrophic Cardiomyopathy
2002 Standout
Prevalence and Incidence of Arrhythmias and Sudden Death in Heart Failure
2002
Long-Term Effects of Dual-Chamber Pacing With Periodic Echocardiographic Evaluation of Optimal Atrioventricular Delay in Patients With Hypertrophic Cardiomyopathy >50 Years of Age
2006
Expression and role of phosphodiesterase 6 in the chicken pineal gland
2001
Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005)
2005 Standout
Predictors of appropriate implantable cardioverter-defibrillator therapy in patients with idiopathic dilated cardiomyopathy
2002
Herb-Drug Interactions
2005 Standout
Role of phosphodiesterases III and IV in the modulation of vascular cyclic AMP content by the NO/cyclic GMP pathway
1994
The growing use of herbal medicines: issues relating to adverse reactions and challenges in monitoring safety
2014 Standout
Congenital Short QT Syndrome and Implantable Cardioverter Defibrillator Treatment:
2003
Catheter ablation of stable ventricular tachycardia before defibrillator implantation in patients with coronary heart disease (VTACH): a multicentre randomised controlled trial
2010
Eplerenone, a Selective Aldosterone Blocker, in Patients with Left Ventricular Dysfunction after Myocardial Infarction
2003 Standout
Herbal bioactivation: The good, the bad and the ugly
2003
Instrumentation and calibration protocol for imaging dynamic features in dense-scattering media by optical tomography
2000
glycyrrhizin as a potential treatment for chronic hepatitis C
1998
Intake of very long-chain n-3 fatty acids from fish and incidence of atrial fibrillation. The Rotterdam Study
2006
A review on continuous wave functional near-infrared spectroscopy and imaging instrumentation and methodology
2013 Standout
Cyclic nucleotide crosstalk and the regulation of cerebral vasodilation
1998
Effects of n–3 fatty acids from fish on premature ventricular complexes and heart rate in humans
2005
Chronic Kidney Disease
2016 Standout
Comparative study of the vasorelaxant activity, superoxide-scavenging ability and cyclic nucleotide phosphodiesterase-inhibitory effects of hesperetin and hesperidin
2004
Biological effects of essential oils – A review
2007 Standout
Dynamic optical coherence tomography in studies of optical clearing, sedimentation, and aggregation of immersed blood
2002
Noninvasive and Minimally Invasive Methods for Transdermal Glucose Monitoring
2005
Hydrogels in Biology and Medicine: From Molecular Principles to Bionanotechnology
2006 Standout
ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult
2005 Standout
Noninvasive monitoring of glucose concentration with optical coherence tomography
2001
Influence of a superficial layer in the quantitative spectroscopic study of strongly scattering media
1998
Patients With Valvular Heart Disease Presenting With Sustained Ventricular Tachyarrhythmias or Syncope
1997
Continuous amperometric monitoring of glucose in a brittle diabetic chimpanzee with a miniature subcutaneous electrode
1998
Dialysis Dose and Intradialytic Hypotension: Results from the HEMO Study
2013 Standout
Magnesium in Man: Implications for Health and Disease
2014 Standout
Use of sildenafil (Viagra) in patients with cardiovascular disease
1999
2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy
2011 Standout
Accuracy of the One-Point in Vivo Calibration of “Wired” Glucose Oxidase Electrodes Implanted in Jugular Veins of Rats in Periods of Rapid Rise and Decline of the Glucose Concentration
1998
High-Value Components and Bioactives from Sea Cucumbers for Functional Foods—A Review
2011 Standout
2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death
2015 Standout
Optical coherence tomography - principles and applications
2003 Standout
Update on Uses and Properties of Citrus Flavonoids: New Findings in Anticancer, Cardiovascular, and Anti-inflammatory Activity
2008 Standout
Empirical Versus Tested Antitachycardia Pacing in Implantable Cardioverter Defibrillators
1998
Phosphodiesterase 4D is required for β 2 adrenoceptor subtype-specific signaling in cardiac myocytes
2005 StandoutNobel
Diffuse backscattering Mueller matricesof highly scattering media
1997
Immersion Clearing of Human Blood in the Visible and Near-Infrared Spectral Regions
2005
ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities
2008 Standout
Optical properties of human skin, subcutaneous and mucous tissues in the wavelength range from 400 to 2000 nm
2005 Standout
K/DOQI Clinical Practice Guidelines for Cardiovascular Disease in Dialysis Patients
2005
Adverse Events With Transvenous Implantable Cardioverter-Defibrillators
1998
Electrochemical Glucose Sensors and Their Applications in Diabetes Management
2008 Standout
Biochemistry and Physiology of Cyclic Nucleotide Phosphodiesterases: Essential Components in Cyclic Nucleotide Signaling
2007 Standout
2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes
2014 Standout
Section Review: Cardiovascular & Renal: Cyclic nucleotide phosphodiesterases as therapeutic targets in cardiovascular diseases
1995
Works of D. Böcker being referenced
Polycystic disease of the kidneys complicating the diagnosis of myocardial echinococcosis
1993
Rationale and design of a randomised controlled clinical trial on supplemental intake of n-3 fatty acids and incidence of cardiac arrhythmia: SOFA
2003
Implantation of cardiac resynchronization therapy systems in the CARE-HF trial: procedural success rate and safety
2007
Role of programmed ventricular stimulation in patients with idiopathic dilated cardiomyopathy and documented sustained ventricular tachyarrhythmias: inducibility and prognostic value in 102 patients
1994
Defibrillators are superior to antiarrhythmic drugs in the treatment of ventricular tachyarrhythmias
1997
[Induction of arrhythmia by licorice abuse].
1991
Benefits of treatment with implantable cardioverter-defibrillators in patients with stable ventricular tachycardia without cardiac arrest.
1995
Correlation between blood glucose concentration in diabetics and noninvasively measured tissue optical scattering coefficient
1997
[Inadequate therapies with implantable cardioverter-defibrillators--incidence, etiology, predictive factors and preventive strategies].
1996